EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next

Veronica Venturelli iD, David Alan Isenberg

Journal of Clinical Medicine · 29.04.2023 · 12 (9) · 3198

DOI: 10.3390/jcm12093198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.04.2023. Verfasst von Veronica Venturelli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medical Sciences, Università degli Studi di Ferrara, Azienda Ospedaliero-Universitaria S. Anna, 44124 Cona, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For many years, the failure of randomized controlled trials (RCTs) has prevented patients with systemic lupus erythematosus (SLE) from benefiting from biological drugs that have proved to be effective in other rheumatological diseases. Only two biologics are approved for SLE, however they can only be administered to a restricted proportion of patients. Recently, several phase II RCTs have evaluated the efficacy and safety of new biologics in extra-renal SLE and lupus nephritis. Six drug trials have reported encouraging results, with an improvement in multiple clinical and serological outcome measures. The possibility of combining B-cell depletion and anti-BLyS treatment has also been successfully explored.

Schlagwörter

Stichwörter der Autor:innen

biological therapiescombination therapieslupus nephritissystemic lupus erythematosustrials

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Medical Sciences, Università degli Studi di Ferrara, Azienda Ospedaliero-Universitaria S. Anna, 44124 Cona, Italy.
  • Centre for Rheumatology, Department of Medicine, University College London, London WC1E 6JF, UK.

ORCID-Profile: Veronica Venturelli

Zitieren

APA

Venturelli, V., & Isenberg, D. A. (2023). Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next. Journal of Clinical Medicine, 12(9), 3198. https://doi.org/10.3390/jcm12093198

Vancouver

Venturelli V, Isenberg DA. Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next. Journal of Clinical Medicine. 2023;12(9):3198. doi:10.3390/jcm12093198

BibTeX
@article{Venturelli2023,
  author = {Venturelli, Veronica and Isenberg, David Alan},
  title = {Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {3198},
  doi = {10.3390/jcm12093198}
}
Kostenlos starten →